{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T06:26:08Z","timestamp":1787207168720,"version":"build-2736575974"},"posted":{"date-parts":[[2026,8,5]]},"group-title":"In Review","reference-count":0,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,7,22]]},"abstract":"<title>Abstract<\/title>\n                <p>\n                  Objective\n Deficient IL10 signaling can contribute to macrophage activation syndrome. We hypothesized that in TLR-9-mediated inflammation, blocking IL10 would increase T cell activation and worsen organ dysfunction.\nMethods\n C57BL\/6 mice (n\u2009=\u20093\u201311\/cohort) were injected with A) CpG ODN1826, a TLR9 agonist, 50\u00b5g every other day for 5 doses on days\u2009\u2212\u20098 \u2014 0 (CpGLo), B) CpG 500\u00b5g on Day 0 (CpGHi), or C) CpGHi+\u237aIL10-R blocking antibody. OTI and OTII mice, which respectively contain CD8 and CD4 cells with transgenic T cell receptors, do not respond to antigens. Wild-type C57Bl\/6, OTI, and OTII mice received CpGHi+\u237aIL10-R. Baseline (untreated) mice were included in each experiment. Animals were sacrificed one day post-challenge.\nResults\n The CpGHi cohort had lower WBC (p\u2009&lt;\u20090.0001), higher ferritin (p\u2009=\u20090.0035) and higher ALT (p\u2009&lt;\u20090.05) and lower bile acid transporter mRNA levels (p\u2009&lt;\u20090.05). The CpGHi cohort had increased percentages of B cells expressing activation markers (CD80, CD86, and MHC-I, p\u2009&lt;\u20090.05), of dendritic cells expressing CD86 (p\u2009=\u20090.03), and of CD4 (p\u2009&lt;\u20090.0001) and CD8 (p\u2009=\u20090.025) T cells expressing CD69. Compared to CpGHi, CpGHi+\u237aIL10-R treatment increased Nur77 expression on CD4 and CD8 T cells (p\u2009&lt;\u20090.0001), did not alter innate immune cells, and was associated with worse liver function (p\u2009&lt;\u20090.05). We noted significant expansion of Nur77\n                  <sup>+<\/sup>\n                  CD69\n                  <sup>+<\/sup>\n                  CD8 T cells in OTI and OTII mice, indicating an autoreactive CD8 T cell response.\nConclusions\n In TLR9-induced hyperinflammation, IL10 restrained a feedforward loop of innate and T cell activation. The specificity of the innate and T cell interaction is unclear and may represent an autoimmune activation of CD8 T cells.\n                <\/p>","DOI":"10.21203\/rs.3.rs-10449618\/v1","type":"posted-content","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T15:33:59Z","timestamp":1785944039000},"source":"Crossref","is-referenced-by-count":0,"title":["Loss of IL10 Signaling Promotes TLR9-Driven Liver Dysfunction by Allowing T Cell Receptor-Mediated T Cell Activation"],"prefix":"10.21203","author":[{"given":"Grace","family":"Fisler","sequence":"first","affiliation":[{"name":"Cohen Children\u2019s Medical Center of New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Eremita","sequence":"additional","affiliation":[{"name":"Cohen Children\u2019s Medical Center of New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivani","family":"Chhabra","sequence":"additional","affiliation":[{"name":"Cohen Children\u2019s Medical Center of New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana R.","family":"Brewer","sequence":"additional","affiliation":[{"name":"Cohen Children\u2019s Medical Center of New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Qi","sequence":"additional","affiliation":[{"name":"Cohen Children\u2019s Medical Center of New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce Hui","family":"Yuen","sequence":"additional","affiliation":[{"name":"Cohen Children\u2019s Medical Center of New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifford S.","family":"Deutschman","sequence":"additional","affiliation":[{"name":"Cohen Children\u2019s Medical Center of New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Taylor","sequence":"additional","affiliation":[{"name":"Cohen Children\u2019s Medical Center of New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10449618\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10449618\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T06:11:32Z","timestamp":1787206292000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10449618\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,5]]},"references-count":0,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-10449618\/v1","relation":{},"subject":[],"published":{"date-parts":[[2026,8,5]]},"subtype":"preprint"}}